News

A new master’s program in Biomedical Engineering and Medical Physics at the Technical University of Munich (TUM) will begin in the summer semester 2020. Applications are now open and will be accepted until 30 November 2019. The program is provided by the Munich School of BioEngineering – an interdisciplinary research center at TUM.

Two MSB-PIs – Daniel Cremers and Dimitrios Karampinos – have been awarded prestigious Proof-of-Concept Grants by the European Research Council (ERC).

09 September 2019 | Faszination Forschung – the science magazine of the Technical University of Munich (TUM) – reported on the work at the Bavarian NMR Center (BNMRZ) at TUM. 

04 September 2019 | German public radio (Deutschlandfunk) reported on the work of MSB-PI Vasilis Ntziachristos and his colleagues at the TUM professorship of Biological Imaging and the Institute for Biological and Medical Imaging at the Helmholtz Zentrum München.

27 August 2019 | Researchers at TUM and the Helmholtz Zentrum München have moved a step closer towards developing innovative drug molecules for the treatment of psychiatric diseases. They discovered how inhibitors inactivate a special protein that plays a key role in various diseases. Their approach can be applied to other medically relevant proteins where the development of specific inhibitors has proved difficult up to now. The research effort was led by Michael Sattler, Director of the Institute of Structural Biology at the Helmholtz Zentrum München and Professor of Biomolecular NMR-Spectroscopy at TUM as well as Principal Investigator at the MSB.

14 August 2019 | Cause of early cellular dysfunction in Alzheimer’s disease recognized for the first time.

08 August 2019 | Self-assembling nanoparticles mark cells in electron microscopy.

08 August 2019 | The scGen computer model, developed by scientists at the Technical University of Munich (TUM) and Helmholtz Zentrum München, predicts how cells will behave. The software uses artificial intelligence to model the response of a cell to a disease or treatment – with no need for experimental data from pertubed human cells.

In the Munich Business Plan Competition, the third prize went to the company Orbem, a start-up founded at the Munich School of BioEngineering. Orbem has developed a method for identifying the sex of poultry embryos still in the egg. The first and second spots were also claimed by start-ups incubated at the Technical University of Munich (TUM).

01 July 2019 | A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was once a pharmacologist's dream is now much closer to reality. With a combination of hydrogels and artificial DNA, nanoparticles can be released in sequence under conditions similar to those in the human body.